Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl H June

Showing results (111-120 of 460) with videos related to

Pageof 46
Sort By:
Oncotarget|February 16, 2017
A versatile system for rapid multiplex genome-edited CAR T cell generationJiangtao Ren, Xuhua Zhang, Xiaojun Liu, et al.
Human Gene Therapy|July 26, 2013
Regimen-specific effects of RNA-modified chimeric antigen receptor T cells in mice with advanced leukemiaDavid M Barrett, Xiaojun Liu, Shuguang Jiang, et al.
Journal for Immunotherapy of Cancer|May 16, 2014
Expression of miR-17-92 enhances anti-tumor activity of T-cells transduced with the anti-EGFRvIII chimeric antigen receptor in mice bearing human GBM xenograftsMasasuke Ohno, Takayuki Ohkuri, Akemi Kosaka, et al.
Neuro-Oncology|March 7, 2018
CAR T-cell therapy for glioblastoma: recent clinical advances and future challengesStephen J Bagley, Arati S Desai, Gerald P Linette, et al.
Clinical Immunology (Orlando, Fla.)|December 25, 2002
A cell-based artificial antigen-presenting cell coated with anti-CD3 and CD28 antibodies enables rapid expansion and long-term growth of CD4 T lymphocytesAnna K Thomas, Marcela V Maus, Waleed S Shalaby, et al.
Clinical Immunology (Orlando, Fla.)|February 14, 2003
HLA tetramer-based artificial antigen-presenting cells for stimulation of CD4+ T cellsMarcela V Maus, James L Riley, William W Kwok, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2003
CD28 and inducible costimulatory protein Src homology 2 binding domains show distinct regulation of phosphatidylinositol 3-kinase, Bcl-xL, and IL-2 expression in primary human CD4 T lymphocytesRichard V Parry, Catherine A Rumbley, Luk H Vandenberghe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2004
SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activationJens M Chemnitz, Richard V Parry, Kim E Nichols, et al.
American Journal of Hematology|January 25, 2024
Adoptive cellular therapy after hematopoietic stem cell transplantationPongthep Vittayawacharin, Piyanuch Kongtim, Yaya Chu, et al.
Scientific Reports|February 7, 2024
ZFP36 disruption is insufficient to enhance the function of mesothelin-targeting human CAR-T cellsDavid Mai, Tifara Boyce, Aakash Mehta, et al.
Pageof 46

Showing results (111-120 of 460) with videos related to

Sort By:
Pageof 46
Oncotarget|February 16, 2017
A versatile system for rapid multiplex genome-edited CAR T cell generationJiangtao Ren, Xuhua Zhang, Xiaojun Liu, et al.
Human Gene Therapy|July 26, 2013
Regimen-specific effects of RNA-modified chimeric antigen receptor T cells in mice with advanced leukemiaDavid M Barrett, Xiaojun Liu, Shuguang Jiang, et al.
Journal for Immunotherapy of Cancer|May 16, 2014
Expression of miR-17-92 enhances anti-tumor activity of T-cells transduced with the anti-EGFRvIII chimeric antigen receptor in mice bearing human GBM xenograftsMasasuke Ohno, Takayuki Ohkuri, Akemi Kosaka, et al.
Neuro-Oncology|March 7, 2018
CAR T-cell therapy for glioblastoma: recent clinical advances and future challengesStephen J Bagley, Arati S Desai, Gerald P Linette, et al.
Clinical Immunology (Orlando, Fla.)|December 25, 2002
A cell-based artificial antigen-presenting cell coated with anti-CD3 and CD28 antibodies enables rapid expansion and long-term growth of CD4 T lymphocytesAnna K Thomas, Marcela V Maus, Waleed S Shalaby, et al.
Clinical Immunology (Orlando, Fla.)|February 14, 2003
HLA tetramer-based artificial antigen-presenting cells for stimulation of CD4+ T cellsMarcela V Maus, James L Riley, William W Kwok, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2003
CD28 and inducible costimulatory protein Src homology 2 binding domains show distinct regulation of phosphatidylinositol 3-kinase, Bcl-xL, and IL-2 expression in primary human CD4 T lymphocytesRichard V Parry, Catherine A Rumbley, Luk H Vandenberghe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2004
SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activationJens M Chemnitz, Richard V Parry, Kim E Nichols, et al.
American Journal of Hematology|January 25, 2024
Adoptive cellular therapy after hematopoietic stem cell transplantationPongthep Vittayawacharin, Piyanuch Kongtim, Yaya Chu, et al.
Scientific Reports|February 7, 2024
ZFP36 disruption is insufficient to enhance the function of mesothelin-targeting human CAR-T cellsDavid Mai, Tifara Boyce, Aakash Mehta, et al.
Pageof 46